Published in PLoS One on July 25, 2014
Aspirin Action in Endothelial Cells: Different Patterns of Response Between Chemokine CX3CL1/CX3CR1 and TNF-α/TNFR1 Signaling Pathways. Cardiovasc Drugs Ther (2015) 0.75
The PIK3/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia. Acta Pharmacol Sin (2017) 0.75
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (1997) 24.57
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (1998) 16.08
Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell (1998) 13.87
The pathophysiology of mitochondrial cell death. Science (2004) 13.87
The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol (2000) 9.87
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J (1995) 7.60
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell (1999) 2.74
Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene (2006) 2.60
Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem (2001) 2.40
TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov (2010) 2.17
Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science (1999) 2.14
Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci U S A (2001) 1.90
Treatment of adult acute lymphoblastic leukemia. Semin Hematol (2009) 1.87
Taxol induces caspase-10-dependent apoptosis. J Biol Chem (2004) 1.62
MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD). J Invest Dermatol (2012) 1.59
TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. Oncogene (2003) 1.57
Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect. J Pharmacol Exp Ther (2002) 1.41
Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia (2003) 1.40
Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol (2007) 1.40
NO-aspirins: a class of new anti-inflammatory and antithrombotic agents. Trends Pharmacol Sci (1999) 1.34
Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol (2003) 1.33
Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood (2002) 1.30
Comparative analysis of apoptosis and inflammation genes of mice and humans. Genome Res (2003) 1.26
Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia. Blood (2009) 1.21
Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc (2010) 1.15
AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat Cell Biol (2007) 1.14
Simplified apoptotic cascades. Heart Fail Rev (2008) 1.14
Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway. PLoS One (2010) 1.07
Isolation and characterization of a novel receptor-type protein tyrosine kinase (hek) from a human pre-B cell line. J Biol Chem (1992) 1.05
Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1. Oncogene (1998) 1.03
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2010) 1.01
Arsenic trioxide promotes histone H3 phosphoacetylation at the chromatin of CASPASE-10 in acute promyelocytic leukemia cells. J Biol Chem (2002) 1.00
Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms. Blood (1993) 0.99
Caspase 10 levels are increased following DNA damage in a p53-dependent manner. Cancer Biol Ther (2003) 0.97
Enhanced expression of Silencer of death domains (SODD/BAG-4) in pancreatic cancer. Biochem Biophys Res Commun (2000) 0.97
The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia. Haematologica (2010) 0.97
BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer. Clin Cancer Res (2007) 0.94
Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia. Haematologica (2007) 0.94
Caspase-10 involvement in cytotoxic drug-induced apoptosis of tumor cells. Oncogene (2006) 0.93
Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis. Biochem Pharmacol (2008) 0.88
Role of SODD in regulation of tumor necrosis factor responses. Mol Cell Biol (2003) 0.88
Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts. Cell Death Differ (2001) 0.88
Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies. Exp Hematol (2001) 0.87
Oxidative stress promotes ligand-independent and enhanced ligand-dependent tumor necrosis factor receptor signaling. J Biol Chem (2008) 0.86
p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism. Cell Cycle (2007) 0.85
Para-NO-aspirin inhibits NF-κB and induces apoptosis in B-cell progenitor acute lymphoblastic leukemia. Exp Hematol (2011) 0.82
Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells. Leukemia (1997) 0.81
Overexpression of the 'silencer of death domain', SODD/BAG-4, modulates both TNFR1- and CD95-dependent cell death pathways. Cancer Lett (2003) 0.81
Expression of SODD and P65 in ALL of children and its relationship with chemotherapeutic drugs. J Huazhong Univ Sci Technolog Med Sci (2007) 0.81
Apparently normal tumor necrosis factor receptor 1 signaling in the absence of the silencer of death domains. Mol Cell Biol (2003) 0.79
Downregulation of caspase-10 predicting poor survival after resection of stage II colorectal cancer. Int J Colorectal Dis (2011) 0.78
Human acute myeloid leukaemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins. Leukemia (1993) 0.77
Effects of recombinant human cytokines on precursor-B acute lymphoblastic leukemia cells. Exp Hematol (1991) 0.76
Tumour necrosis factor alpha (TNF alpha) and leukaemic cells: secretion and response. Clin Lab Haematol (1998) 0.76